SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-038165
Filing Date
2024-03-25
Accepted
2024-03-25 07:37:24
Documents
14
Period of Report
2024-03-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249644d1_8k.htm   iXBRL 8-K 41022
5 GRAPHIC tm249644d1_8kimg003.jpg GRAPHIC 53514
  Complete submission text file 0001104659-24-038165.txt   361487

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20240325.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20240325_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20240325_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT tm249644d1_8k_htm.xml XML 3616
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 24776900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)